Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Resurrect Bio
United Kingdom
- London
- 17/05/2023
- Unknown
- $2,000,000
We are a plant biotech start-up, based in London. We're working on how to improve the immune system of crop species.
Crops were bred over generations by plant breeders to improve key traits such as yield, height or drought-tolerance, but sometimes inadvertently lost key immune resistance genes.
Additionally, modern monocultures are static in evolution, but the pests and pathogens that threaten them are not. Plant diseases are constantly evolving new ways of defeating the R-genes in crops.
Climate change is making matters worse – diseases are spreading to new locations, meaning the disease spectrum farmers are dealing with is expanding.
- Industry Biotechnology Research
- Website https://resurrect.bio/
- LinkedIn https://www.linkedin.com/company/resurrect-bio/
Related People
Cian DugganCo Founder
United Kingdom -
ND
Note about LinkedIn: I only accept connections from those who I've met, sorry.
I'm leading an innovative plant disease resistance discovery company, figuring out how to use gene editing to engineer disease resistant crops and licencing this to plant breeders.
My PhD was: molecular biology research on how plants attempt to defend themselves against diseases, in an effort to ultimately improve crop resistance.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)